Envista Holdings shares surge 12.91% after-hours as Stifel and Wells Fargo raise price targets, and William Blair upgrades rating to Outperform.

Envista Holdings (NVST) surged 12.91% in after-hours trading following a series of analyst upgrades and strong Q4 2025 results. The stock gained momentum as Piper Sandler raised its price target to $25 from $21, Stifel increased its target to $31 (a 14.81% jump), and William Blair upgraded the rating to Outperform. Wells Fargo also raised its target to $26 from $21. Envista’s Q4 2025 sales grew 10.8% year-on-year to $750.6 million, with adjusted EPS of $0.38, exceeding expectations. These analyst actions and robust sales data collectively signaled renewed confidence in the dental products company’s growth trajectory, driving the post-market rally.